| Section | Title | Authors | Address |
|---|
|
| Genes | ARHGAP21 (Rho GTPase activating protein 21) | Ferreira Pissarra M, Olalla Saad ST, Lazarini M | http://atlasgeneticsoncology.org/Genes/ARHGAP21ID43137ch10p12.html |
| Genes | ATG2B (Autophagy-related 2B) | Bellanné-Chantelot C, Plo I | http://atlasgeneticsoncology.org/Genes/ATG2BID55326ch14q32.html |
| Genes | ATM (ataxia telangiectasia mutated) | Shiloh Y | http://atlasgeneticsoncology.org/Genes/ATMID123.html |
| Genes | CALR (calreticulin) | Machado-Neto JA, de Melo Campos P, Traina F | http://atlasgeneticsoncology.org/Genes/CALRID904ch19p13.html |
| Genes | CFAP99 (Cilia and Flagella Associated Protein 99) | Tunçer S, Gurbanov R | http://atlasgeneticsoncology.org/Genes/CFAP99ID61767ch4p16.html |
| Genes | DAPK2 (death-associated protein kinase 2) | Pinto M, Máximo V | http://atlasgeneticsoncology.org/Genes/DAPK2ID40263ch15q22.html |
| Genes | DOT1L (DOT1 like histone H3K79 methyltransferase) | Bernt KM, Neff T | http://atlasgeneticsoncology.org/Genes/DOT1LID43797ch19p13.html |
| Genes | EEF2K (eukaryotic elongation factor 2 kinase) | Ozpolat B, Ozkayar O | http://atlasgeneticsoncology.org/Genes/EEF2KID40411ch16p12.html |
| Genes | FMNL1 (formin like 1) | Rodrigues Lopes, Favaro P | http://atlasgeneticsoncology.org/Genes/FMNL1ID46313ch17q21.html |
| Genes | GSKIP (GSK3-beta interaction protein) | Bellanné-Chantelot C, Plo I | http://atlasgeneticsoncology.org/Genes/GSKIPID64074ch14q32.html |
| Genes | HLTF (helicase-like transcription factor) | Dhont L, Belayew A | http://atlasgeneticsoncology.org/Genes/HLTFID42332ch3q24.html |
| Genes | HMGN5 (High Mobility Group Nucleosome binding domain 5) | Bustin M, Furusawa T | http://atlasgeneticsoncology.org/Genes/HMGN5ID52454chXq21.html |
| Genes | HNF4A (Hepatocyte Nuclear Factor 4 alpha) | Tunçer S, Banerjee S | http://atlasgeneticsoncology.org/Genes/HNF4AID44014ch20q13.html |
| Genes | IRS2 (insulin receptor substrate 2) | Machado-Neto JA, de Melo Campos P, Traina F | http://atlasgeneticsoncology.org/Genes/IRS2ID40994ch13q34.html |
| Genes | KLK12 (kallikrein-related peptidase 12) | Kontos CK, Scorilas A | http://atlasgeneticsoncology.org/Genes/KLK12ID41078ch19q13.html |
| Genes | KLK13 (kallikrein-related peptidase 13) | Adamopoulos PG, Scorilas A | http://atlasgeneticsoncology.org/Genes/KLK13ID41079ch19q13.html |
| Genes | KLK14 (kallikrein-related peptidase 14) | Kontos CK, Scorilas A | http://atlasgeneticsoncology.org/Genes/KLK14ID41080ch19q13.html |
| Genes | KLK9 (kallikrein-related peptidase 9) | Adamopoulos PG, Scorilas A | http://atlasgeneticsoncology.org/Genes/KLK9ID47324ch19q13.html |
| Genes | KNL1 (cancer susceptibility candidate 5) | Takimoto M, Huret JL | http://atlasgeneticsoncology.org/Genes/AF15q14ID318.html |
| Genes | LMDRA (leucine rich melanocyte differentiation associated) | Ray K, Sengupta M, Ghosh S | http://atlasgeneticsoncology.org/Genes/C10orf11ID60852ch10q22.html |
| Genes | MIR150 | Arjmand M | http://atlasgeneticsoncology.org/Genes/MIR150ID50556ch19q13.html |
| Genes | OCA2 (OCA2 melanosomal transmembrane protein) | Ray K, Sengupta M, Ghosh S | http://atlasgeneticsoncology.org/Genes/OCA2ID45789ch15q12.html |
| Genes | PARK7 (Parkinsonism associated deglycase) | La Cognata V, Cavallaro S | http://atlasgeneticsoncology.org/Genes/PARK7ID41639ch1p36.html |
| Genes | PAWR (PRKC apoptosis WT1 regulator protein; Prostate apoptosis response-4, Par-4) | Shukla N, Zhao Y, Rangnekar V | http://atlasgeneticsoncology.org/Genes/PAWRID41641ch12q21.html |
| Genes | PDCD10 (Programmed cell death 10) | Urfali-Mamatoglu C, Kasan HH, Gunduz U | http://atlasgeneticsoncology.org/Genes/PDCD10ID43399ch3q26.html |
| Genes | PPP2R1A (protein phosphatase 2 regulatory subunit A, alpha) | Sultana R, Nakayama K, Nakamura K, Kyo S | http://atlasgeneticsoncology.org/Genes/PPP2R1AID41814ch19q13.html |
| Genes | PTPN9 (protein tyrosine phosphatase, non-receptor type 9) | Nyesiga B, Gjörloff Wingren A | http://atlasgeneticsoncology.org/Genes/PTPN9ID41922ch15q24.html |
| Genes | RAB31 (Ras-related protein in brain 31) | Kotzsch M, Goettig P, Soelch S, Magdolen V | http://atlasgeneticsoncology.org/Genes/RAB31ID41978ch18p11.html |
| Genes | RACGAP1 (Rac GTPase activating protein 1) | Strimpakos A, Sampaziotis D, Psyrri A | http://atlasgeneticsoncology.org/Genes/RACGAP1ID46389ch12q13.html |
| Genes | RHOBTB1 (Rho-related BTB domain containing 1) | Schenková K, Cai S, Rivero F | http://atlasgeneticsoncology.org/Genes/RHOBTB1ID42981ch10q22.html |
| Genes | RHOBTB2 (Rho-related BTB domain containing 2) | Schenková K, Cai S, Rivero F | http://atlasgeneticsoncology.org/Genes/RHOBTB2ID42109ch8p21.html |
| Genes | RHOBTB3 (Rho-related BTB domain containing 3) | Cai S, Rivero F | http://atlasgeneticsoncology.org/Genes/RHOBTB3ID43467ch5q15.html |
| Genes | SLC24A5 (solute carrier family 24 (sodium/potassium/calcium exchanger), member 5) | Ray K, Sengupta M, Ghosh S | http://atlasgeneticsoncology.org/Genes/SLC24A5ID73332ch15q21.html |
| Genes | SPARC (secreted protein acidic and cysteine-rich) | Pavanelli AC, Mangone FR, Nagai MA. | http://atlasgeneticsoncology.org/Genes/SPARCID42369ch5q31.html |
| Genes | SYK (spleen tyrosine kinase) | Nyesiga B, Gjörloff Wingren A | http://atlasgeneticsoncology.org/Genes/SYKID394.html |
| Genes | TP53 (Tumour protein p53 (Li-Fraumeni syndrome)) | Soussi T | http://atlasgeneticsoncology.org/Genes/P53ID88.html |
| Genes | TYRP1 (tyrosinase-related protein 1) | Ray K, Sengupta M, Ghosh S | http://atlasgeneticsoncology.org/Genes/TYRP1ID46370ch9p23.html |
| Leukemias | Alpha heavy chain disease | Bianchi G, Anderson K | http://atlasgeneticsoncology.org/Anomalies/AlphaHeavyChainID2029.html |
| Leukemias | Anaplastic large cell lymphoma, ALK-negative | Boddicker RL, Feldman AL | http://atlasgeneticsoncology.org/Anomalies/ALCLALKnegID1705.html |
| Leukemias | B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma | Carbone A, Pantanowitz L, Sulfaro S, Gloghini A | http://atlasgeneticsoncology.org/Anomalies/IntermediateDLBCL-cHDID2131.html |
| Leukemias | Classical Hodgkin lymphoma | Carbone A, Gloghini A | http://atlasgeneticsoncology.org/Anomalies/ClassicHodgkinID1569.html |
| Leukemias | Classification of Hodgkin lymphoma over years | Carbone A, Gloghini A | http://atlasgeneticsoncology.org/Anomalies/ClassifHodgkinID1767.html |
| Leukemias | Disseminated Juvenile Xanthogranuloma | Dalia S, Juarez Salcedo LM | http://atlasgeneticsoncology.org/Anomalies/DisseminJuvXanthogranulomID1716.html |
| Leukemias | Follicular Dendritic Cell Sarcoma | Shahryari J, Ohgami R S | http://atlasgeneticsoncology.org/Anomalies/FollDendriticCellSarcID1719.html |
| Leukemias | Gamma heavy chain disease | Bianchi G, Anderson K | http://atlasgeneticsoncology.org/Anomalies/GammaHeavyChainID1721.html |
| Leukemias | HIV-associated lymphomas | Gloghini A, Carbone A, Pantanowitz L | http://atlasgeneticsoncology.org/Anomalies/LymphomAssocHIVID1732.html |
| Leukemias | In situ follicular neoplasia | Carbone A, Gloghini A | http://atlasgeneticsoncology.org/Anomalies/InSituFollicNeoplasID1757.html |
| Leukemias | Infectious mononucleosis-like PTLD | Chen DB | http://atlasgeneticsoncology.org/Anomalies/InfectMononucl-likePTLDID1726.html |
| Leukemias | Lymphocyte depletion classical Hodgkin lymphoma | Carbone A, Gloghini A | http://atlasgeneticsoncology.org/Anomalies/LymphoDepletClassicHodgkinID1568.html |
| Leukemias | Lymphocyte-rich classical Hodgkin lymphoma | Gloghini A, Carbone A | http://atlasgeneticsoncology.org/Anomalies/LymphRichClassicHodgkinID1567.html |
| Leukemias | Mediastinal Gray Zone Lymphoma | Salcedo LMJ, Dalia S | http://atlasgeneticsoncology.org/Anomalies/MediastGrayZoneLymphID1766.html |
| Leukemias | Mixed cellularity classical Hodgkin lymphoma (MCcHL) | Carbone A, Gloghini A | http://atlasgeneticsoncology.org/Anomalies/MixedCellulClassicHodgkinID1566.html |
| Leukemias | Mu heavy chain disease | Bianchi G, Anderson K | http://atlasgeneticsoncology.org/Anomalies/MuHeavyChainID1740.html |
| Leukemias | Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) | Koo M, Ohgami RS | http://atlasgeneticsoncology.org/Anomalies/MDS-MPN-RS-TID1396.html |
| Leukemias | Nodular lymphocyte-predominant Hodgkin lymphoma | Gloghini A, Carbone A | http://atlasgeneticsoncology.org/Anomalies/NodulLymphPredomClassicHodgkinID1570.html |
| Leukemias | Nodular sclerosis classical Hodgkin lymphoma (NScHL) | Carbone A, Gloghini A | http://atlasgeneticsoncology.org/Anomalies/NodulSclerosClassicHodgkinID1565.html |
| Leukemias | Pediatric-type Follicular Lymphoma | Ozawa MG, Ohgami RS | http://atlasgeneticsoncology.org/Anomalies/PediatrFLID1749.html |
| Leukemias | Plasmablastic lymphoma (PBL) | Meloni-Ehrig A, Hertzberg L | http://atlasgeneticsoncology.org/Anomalies/PlasmablasticLymphomaID1564.html |
| Leukemias | Primary mediastinal B-cell lymphoma (PMBL) | Juárez Salcedo LM, Dalia S | http://atlasgeneticsoncology.org/Anomalies/PrimMediastiBLymphomID1477.html |
| Leukemias | T-cell/histiocyte rich large B-cell lymphoma | Carbone A, Gloghini A | http://atlasgeneticsoncology.org/Anomalies/TcellHistioRichLBcellNHLID1764.html |
| Leukemias | del (5q) solely in Myelodysplastic syndrome | Shahmarvand N, Ohgami RS | http://atlasgeneticsoncology.org/Anomalies/del5qSoleID1134.html |
| Leukemias | del(13q) in chronic lymphocytic leukemia | Juárez Salcedo LM, Dalia S | http://atlasgeneticsoncology.org/Anomalies/del13qCLLID1208.html |
| Leukemias | del(5)(q32q33) EBF1/PDGFRB | Decool G, Ducourneau B, Duployez N, Roche-Lestienne C. | http://atlasgeneticsoncology.org/Anomalies/del05q32q33EBF1PDGFRBID1712.html |
| Leukemias | del(9p) in Acute Lymphoblastic Leukemia | Mohamed AN | http://atlasgeneticsoncology.org/Anomalies/del9pALLID1064.html |
| Leukemias | der(1)t(1;1)(p36;q11-q32) in hematopoietic malignancies | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/t0101p36q11q32ID1644.html |
| Leukemias | der(1;9)(q10;p10) | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/der0109q10p10ID1647.html |
| Leukemias | der(5)t(1;5)(q12-q25;q13-q35) | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/der5t0105ID1646.html |
| Leukemias | der(9)t(1;9)(q12;q12) | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/der9t0109q12q12ID1649.html |
| Leukemias | der(X)t(X;8)(q28;q11.2) | Gindina T | http://atlasgeneticsoncology.org/Anomalies/t0X08q28q11ID1641.html |
| Leukemias | dic(5;17)(q11-14;p11-13) | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/dic0517q11p11ID1164.html |
| Leukemias | dup (11q) in myeloid malignancies | Zamecnikova A, Al Bahar S | http://atlasgeneticsoncology.org/Anomalies/dup11qMyeloID1629.html |
| Leukemias | dup(1)(q11-q44) in myeloid malignancies | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/dup1q11-q44ID1443.html |
| Leukemias | i(18)(q10) | Mitev L, Grachlyova L, Asenova A | http://atlasgeneticsoncology.org/Anomalies/i18q10ID1052.html |
| Leukemias | i(4p) in myeloid malignancies | Richebourg S | http://atlasgeneticsoncology.org/Anomalies/i4pID1634.html |
| Leukemias | i(X)(p10) in female patients | Gindina T | http://atlasgeneticsoncology.org/Anomalies/iXp10FemaleID1500.html |
| Leukemias | i(X)(p10) in male patients | Gindina T | http://atlasgeneticsoncology.org/Anomalies/iXp10MaleID1496.html |
| Leukemias | inv(3)(p24q26) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/inv3p24q26ID1441.html |
| Leukemias | t(15;17)(q24;q21) PML/RARA | Poddighe PJ, Weghuis DO | http://atlasgeneticsoncology.org/Anomalies/t1517ID1035.html |
| Leukemias | t(1;1)(p36;p36) PRDM16/SKI | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0101p36p36ID1642.html |
| Leukemias | t(1;1)(p36;q41) DUSP10/PRDM16 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0101q41ID1645.html |
| Leukemias | t(1;12)(p36;p13) ETV6/PRDM16 | Duhoux FP, Poirel HA | http://atlasgeneticsoncology.org/Anomalies/t0112p36p13ID1697.html |
| Leukemias | t(1;17)(p36;q21) WNT3 or NSF/PRDM16 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0117p36q21ID2061.html |
| Leukemias | t(1;2)(p36;p21) THADA/PRDM16 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0102p36p21ID1542.html |
| Leukemias | t(1;22)(p36;q11) IGL/PRDM16 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0122p36q11ID1674.html |
| Leukemias | t(1;3)(p36;q21) PSMD2/PRDM16 ??? | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0103ID1002.html |
| Leukemias | t(1;3)(p36;q21) RPN1/PRDM16 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0103p36q21ID2048.html |
| Leukemias | t(1;7)(p36;p12) IKZF1/PRDM16 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0107p36p12ID1656.html |
| Leukemias | t(1;9)(q24;q34) RCSD1/ABL1 | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/t0109q24q34ID2109.html |
| Leukemias | t(2;11)(p21;q23) KMT2A/? | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0211ID1109.html |
| Leukemias | t(2;11)(p21;q23) without KMT2A (MLL) rearrangement | Ruano, AL, Shetty, S | http://atlasgeneticsoncology.org/Anomalies/t0211p21q23ID1333.html |
| Leukemias | t(2;2)(p22;p22) LTBP1/BIRC6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0202p22p22ID1714.html |
| Leukemias | t(3;21)(q26;q11) NRIP1/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0321q26q11ID1464.html |
| Leukemias | t(3;7)(q26;q21) CDK6/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0307q26q21ID1672.html |
| Leukemias | t(3;9)(p13;q34.1) FOXP1/ABL1 | Sanford Biggerstaff JA | http://atlasgeneticsoncology.org/Anomalies/t0309p13q34ID1619.html |
| Leukemias | t(4;11)(q23;p15) NUP98/RAP1GDS1 | Mohamed AN | http://atlasgeneticsoncology.org/Anomalies/t0411q23p15ID1191.html |
| Leukemias | t(5;14)(q35;q11) RANBP17 (or TLX3)/TRD | Bruyère H | http://atlasgeneticsoncology.org/Anomalies/t0514q35q11ID1228.html |
| Leukemias | t(5;17)(q35;q21) without RARA involvement in non-M3 AML | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/t0517q35q21nonRARAID1777.html |
| Leukemias | t(6;9)(p22;q34) DEK/NUP214 in Childhood | Hasle H, Sandahl JD | http://atlasgeneticsoncology.org/Anomalies/t0609p22q34ChildID1359.html |
| Leukemias | t(7;11)(p15;p15) NUP98/HOXA13 | Meloni-Ehrig AM | http://atlasgeneticsoncology.org/Anomalies/t0711p15p15ID1360.html |
| Leukemias | t(7;12)(q36;p13) MNX1/ETV6 | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/t0712ID1177.html |
| Leukemias | t(7;21)(p22;q22) RUNX1/USP42 | Tirado CA | http://atlasgeneticsoncology.org/Anomalies/t0721p22q22ID1449.html |
| Leukemias | t(8;14)(q24;q32) IGH/MYC | van den Berg E, Stevens-Kroef M | http://atlasgeneticsoncology.org/Anomalies/t0814ID1050.html |
| Leukemias | t(8;21)(q22;q22) RUNX1/RUNX1T1 | Kroes W, Stevens-Kroef M | http://atlasgeneticsoncology.org/Anomalies/t0821ID1019.html |
| Leukemias | t(9;11)(p21;q23) KMT2A/MLLT3 | Knijnenburg J, Beverloo HB | http://atlasgeneticsoncology.org/Anomalies/t0911ID1001.html |
| Leukemias | t(X;10)(p11;p12) DDX3X/MLLT10 | Gindina T | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Bone: Angiosarcoma | van Ijzendoorn DGP, Bovée JVMG | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Breast: carcinoma with t(1;3)(p36;q13) PRDM16/BBX | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Kidney: Chromophobe renal cell carcinoma | Dal Cin P, Hirsch MS | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Kidney: Metanephric adenoma | McIntyre K, Hirsch MS | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Kidney: Papillary adenoma | McIntyre K, Hirsch MS | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Kidney: Renal cell carcinoma with t(X;17)(p11;q25) ASPSCR1/TFE3 | Argani P | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Kidney: Renal cell carcinoma with inv(X)(p11q12) NONO/TFE3 | Argani P, Ladanyi M | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Kidney: Renal cell carcinoma with t(6;11)(p21;q12) MALAT1/TFEB | Argani P, Ladanyi M | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Kidney: Renal cell carcinoma with t(X;17)(p11;q23) CLTC/TFE3 | Argani P,Ladanyi M | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Kidney: Renal cell carcinomas with MiT family translocation | Argani P | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Male breast cancer | Moelans CB, van der Groep P, J van Diest P | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | Nervous system: Astrocytoma with t(1;17)(p36;q21) SPOP/PRDM16 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Solid Tumors | t(2;2)(p22;p22) LTBP1/BIRC6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X10p11p12ID1701.html |
| Cancer-Prones | Ataxia telangiectasia (A-T) | Shiloh Y | http://atlasgeneticsoncology.org/Kprones/ataxiaID10003.html |
| Cancer-Prones | Fanconi anemia | Rosselli F | http://atlasgeneticsoncology.org/Kprones/FAID10001.html |
| Deep Insights | Cancer Cytogenomics resources | De Braekeleer E, Huret JL, Mossafa H, Hautaviita K, Dessen P | http://atlasgeneticsoncology.org/Deep/Cancer_CytogenomicsID20145.html |
| Deep Insights | General resources in Genetics and/or Oncology | De Braekeleer E, Huret JL, Mossafa H, Hautaviita K, Dessen P | http://atlasgeneticsoncology.org/Deep/General_ResourcesID20144.html |
| Deep Insights | Internet databases and resources for cytogenetics and cytogenomics | De Braekeleer E, Huret JL, Mossafa H, Hautaviita K, Dessen P | http://atlasgeneticsoncology.org/Deep/Internet_DatabasesID20143.html |
